Cargando…
Correction to: Determination of the absolute oral bioavailability of niraparib by simultaneous administration of a (14)C-microtracer and therapeutic dose in cancer patients
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5754421/ https://www.ncbi.nlm.nih.gov/pubmed/29181573 http://dx.doi.org/10.1007/s00280-017-3474-7 |
| _version_ | 1783290412553732096 |
|---|---|
| author | van Andel, L. Rosing, H. Zhang, Z. Hughes, L. Kansra, V. Sanghvi, M. Tibben, M. M. Gebretensae, A. Schellens, J. H. M. Beijnen, J. H. |
| author_facet | van Andel, L. Rosing, H. Zhang, Z. Hughes, L. Kansra, V. Sanghvi, M. Tibben, M. M. Gebretensae, A. Schellens, J. H. M. Beijnen, J. H. |
| author_sort | van Andel, L. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5754421 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2017 |
| publisher | Springer Berlin Heidelberg |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-57544212018-01-22 Correction to: Determination of the absolute oral bioavailability of niraparib by simultaneous administration of a (14)C-microtracer and therapeutic dose in cancer patients van Andel, L. Rosing, H. Zhang, Z. Hughes, L. Kansra, V. Sanghvi, M. Tibben, M. M. Gebretensae, A. Schellens, J. H. M. Beijnen, J. H. Cancer Chemother Pharmacol Correction Springer Berlin Heidelberg 2017-11-27 2018 /pmc/articles/PMC5754421/ /pubmed/29181573 http://dx.doi.org/10.1007/s00280-017-3474-7 Text en © The Author(s) 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
| spellingShingle | Correction van Andel, L. Rosing, H. Zhang, Z. Hughes, L. Kansra, V. Sanghvi, M. Tibben, M. M. Gebretensae, A. Schellens, J. H. M. Beijnen, J. H. Correction to: Determination of the absolute oral bioavailability of niraparib by simultaneous administration of a (14)C-microtracer and therapeutic dose in cancer patients |
| title | Correction to: Determination of the absolute oral bioavailability of niraparib by simultaneous administration of a (14)C-microtracer and therapeutic dose in cancer patients |
| title_full | Correction to: Determination of the absolute oral bioavailability of niraparib by simultaneous administration of a (14)C-microtracer and therapeutic dose in cancer patients |
| title_fullStr | Correction to: Determination of the absolute oral bioavailability of niraparib by simultaneous administration of a (14)C-microtracer and therapeutic dose in cancer patients |
| title_full_unstemmed | Correction to: Determination of the absolute oral bioavailability of niraparib by simultaneous administration of a (14)C-microtracer and therapeutic dose in cancer patients |
| title_short | Correction to: Determination of the absolute oral bioavailability of niraparib by simultaneous administration of a (14)C-microtracer and therapeutic dose in cancer patients |
| title_sort | correction to: determination of the absolute oral bioavailability of niraparib by simultaneous administration of a (14)c-microtracer and therapeutic dose in cancer patients |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5754421/ https://www.ncbi.nlm.nih.gov/pubmed/29181573 http://dx.doi.org/10.1007/s00280-017-3474-7 |
| work_keys_str_mv | AT vanandell correctiontodeterminationoftheabsoluteoralbioavailabilityofniraparibbysimultaneousadministrationofa14cmicrotracerandtherapeuticdoseincancerpatients AT rosingh correctiontodeterminationoftheabsoluteoralbioavailabilityofniraparibbysimultaneousadministrationofa14cmicrotracerandtherapeuticdoseincancerpatients AT zhangz correctiontodeterminationoftheabsoluteoralbioavailabilityofniraparibbysimultaneousadministrationofa14cmicrotracerandtherapeuticdoseincancerpatients AT hughesl correctiontodeterminationoftheabsoluteoralbioavailabilityofniraparibbysimultaneousadministrationofa14cmicrotracerandtherapeuticdoseincancerpatients AT kansrav correctiontodeterminationoftheabsoluteoralbioavailabilityofniraparibbysimultaneousadministrationofa14cmicrotracerandtherapeuticdoseincancerpatients AT sanghvim correctiontodeterminationoftheabsoluteoralbioavailabilityofniraparibbysimultaneousadministrationofa14cmicrotracerandtherapeuticdoseincancerpatients AT tibbenmm correctiontodeterminationoftheabsoluteoralbioavailabilityofniraparibbysimultaneousadministrationofa14cmicrotracerandtherapeuticdoseincancerpatients AT gebretensaea correctiontodeterminationoftheabsoluteoralbioavailabilityofniraparibbysimultaneousadministrationofa14cmicrotracerandtherapeuticdoseincancerpatients AT schellensjhm correctiontodeterminationoftheabsoluteoralbioavailabilityofniraparibbysimultaneousadministrationofa14cmicrotracerandtherapeuticdoseincancerpatients AT beijnenjh correctiontodeterminationoftheabsoluteoralbioavailabilityofniraparibbysimultaneousadministrationofa14cmicrotracerandtherapeuticdoseincancerpatients |